甲基强的松龙联合阿司匹林治疗对川崎病患儿临床效果及对患儿血清超敏C反应蛋白、B型钠尿肽水平的影响

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (33 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical effect of Methylprednisolone combined with Aspirin on children with Kawasaki diseases and the influence on children′s serum high-sensitivity C-reactive protein (hs-CRP) and B-type natriuretic peptide (BNP). Methods From May 2016 to May 2020, 80 children with Kawasaki diseases admitted to the Department of Pediatric Internal Medicine of Donggang Central Hospital were selected as the research subjects. They were divided into two groups by computer random number method, each with 40 cases. The children in the control group were treated with Aspirin, and the children in the observation group were treated with Methylprednisolone and Aspirin. The clinical symptom improvement time, hospital stay and coronary artery injury were compared between the two groups. The serum levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), hs-CRP and BNP before and after treatment were compared between the two groups. Results In the observation group, the subsidence time of mucosal congestion, hand and foot swelling, neck lymph node enlargement, fever abatement time, rash resolution time and hospital stay time were shorter than those in the control group, with statistical significances (P＜0.05). After 3 months of follow-up, the incidence of coronary artery injury in the observation group was lower than that in the control group, and the difference was statistically significant (P＜0.05). Before treatment, there were no significant differences in serum TNF-α, IL-6, hs-CRP and BNP between the two groups (P＞0.05). After treatment, the levels of TNF-α, IL-6, hs-CRP and BNP in the observation group were lower than those in the control group, with statistical significances (P＜0.05).Conclusion The combination of Methylprednisolone and Aspirin in children with Kawasaki diseases can facilitate improvement of symptoms, reduce coronary artery damage, shorten hospital stay, and greatly improve serum levels of TNF-α, IL-6, hs-CRP, and BNP, which is worthy of application.

Key words： Kawasaki disease Methylprednisolone;Aspirin Clinical effect High-sensitivity C-reactive protein B-type natriuretic peptide

Received: 24 September 2020

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Li-li

Cite this article:

LI Li-li. Clinical effect of Methylprednisolone combined with Aspirin on children with Kawasaki diseases and the influence on children′s serum high-sensitivity C-reactive protein and B-type natriuretic peptide levels[J]. 中国当代医药, 2021, 28(12): 123-126.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I12/123

[1]	赵冬梅，尹千里，米尔扎提·海维尔，等.3 种不同方案治疗川崎病的临床疗效分析[J].新疆医科大学学报，2014，37（12）：1638-1642.
[2]	齐颖，武宇辉，杨燕澜，等.16 例川崎病休克综合征临床分析[J].中国小儿急救医学，2017，24（12）：925-928.
[3]	米尔扎提·海维尔，孟广雨，程秋婷，等.不同方案初次治疗川崎病的疗效观察[J].实用临床医药杂志，2015，19（9）：101-105.
[4]	赵冬梅，尹千里，季雪红，等.肾上腺糖皮质激素联合乌司他丁治疗儿童川崎病的非随机对照临床研究[J].中国当代儿科杂志，2015，19（8）：780-785.
[5]	杜美娜，孟瑞荣.川崎病休克综合征与川崎病临床特征对照分析[J].中国现代医学杂志，2020，30（9）：85-89.
[6]	吴凡，汤卫红，叶姗，等.川崎病急性期血清胱抑素C 水平与冠脉病变的关系[J].中国妇幼健康研究，2020，31（6）：717-721.
[7]	王亚洲，李小明，张笃飞.不同起始剂量阿司匹林及减量方案对川崎病临床疗效的影响[J].岭南心血管病杂志，2020，26（3）：313-316.
[8]	徐闪，何俊明.阿司匹林辅助丙种球蛋白治疗小儿川崎病的应用效果及其对预防冠状动脉病变的作用分析[J].中国妇幼保健，2020，35（7）：1261-1264.
[9]	甄立娜，段晨初，吴晓杰，等.不同剂量人免疫球蛋白对川崎病患儿临床疗效、炎性指标及心功能标志物的影响[J].疑难病杂志，2020，19（7）：691-694，699.
[10]	彭昭娴，黄萍，张丽，等.华法林联合阿司匹林治疗川崎病并多发中型及巨大型冠状脉瘤临床研究[J].中华实用儿科临床杂志，2019，34（21）：1623-1626.
[11]	王春晖，赵宏芳，杨洁，等.丙种球蛋白对川崎病患儿炎症反应氧化应激及基质金属蛋白酶的影响[J].山西医药杂志，2020，49（2）：133-136.
[12]	张天英，颜承云，曲桂霞，等.甲基强的松龙，阿司匹林联合丙种球蛋白治疗川崎病及对患儿体内hs－CRP 和BNP 的影响[J].黑龙江医药科学，2016，39（5）：97-99.
[13]	张慧玲.大剂量丙种球蛋白联合阿司匹林治疗川崎病患儿的临床效果[J].中国医药，2019，14（4）：578-581.
[14]	柳颐龄，王献民，陈婷婷，等.氯吡格雷联合阿司匹林对川崎病并发中小型冠状动脉瘤患儿抗血栓治疗的疗效及安全性研究[J].中国当代儿科杂志，2019，21（8）：801-805.
[15]	孟莉，李晓惠，刘京晶，等.阿司匹林对川崎病患儿抗血小板聚集功能的研究[J].中国实用儿科杂志，2019，34（8）：670-674.